In April, the U.S. Department of Health and Human Services released its 2024 National Strategy for Suicide Prevention. The comprehensive plan comes as suicide deaths among Americans have reached a record high.
Alicia Morgans interviews Omar El-Taji and Ashwin Sachdeva about their JAMA Oncology publication on cardiovascular risks associated with androgen receptor signaling inhibitors (ARSIs) in prostate…
Zach Klaassen and Alicia Morgans discuss the findings from an exploratory analysis of the ARAMIS trial, focusing on the efficacy of darolutamide for non-metastatic castration-resistant…
In a country where just 1 in 4 people in need of treatment services receive any, expanding access to buprenorphine via telehealth is the best way to…
Zach Klaassen welcomes Vitaly Margulis to discuss the ENLIGHTED trial, a phase three study addressing low-grade upper tract urothelial carcinoma. Dr. Margulis explains the necessity…
Dr. Alex Channon currently is a Senior Lecturer in Physical Education and Sport Studies at the University of Brighton, UK. He teaches on undergraduate courses,…
Stanford University scientists’ findings in mice could translate into a radical, needle-free vaccination approach that would also eliminate reactions including fever, swelling and pain.
Axel Heidenreich discusses the final results of the COTRIMS trial, evaluating retroperitoneal lymph node dissection (RPLND) for clinical stage IIA and IIB seminomas. The study…
Phillip Koo and Neal Shore discuss the COBRA trial, which investigates the use of 64Cu-SAR-bisPSMA PET imaging in prostate cancer patients with biochemical recurrence (BCR).…
The incidence of MASH is on the rise. Learn more about determining risk in your patients and the new and emerging therapies available.
California’s goal was to help 2,000 seriously mentally ill people by the end of this year, but data shows fewer than 600 petitions have been…
